Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12-24 Months-Old Burkinabe Children.

Autor:	Sirima, Sodiomon B.1,2 s.sirima.cnlp@fasonet.bf, Tiono, Alfred B.1, Ouédraogo, Alphonse1, Diarra, Amidou1, Ouédraogo, André Lin1, Yaro, Jean Baptiste1, Ouédraogo, Espérance1, Gansané, Adama1, Bougouma, Edith C.1, Konaté, Amadou T.1, Kaboré, Youssouf1, Traoré, Abdoulaye1,2, Roma, Chilengi3, Soulama, Issiaka1, Luty, Adrian J. F.4, Cousens, Simon5, Nébié, Issa1
Zdroj:	PLoS ONE. 2009, Vol. 4 Issue 10, p1-11. 11p. 1 Diagram, 5 Charts, 2 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu